Currently Viewing:
Currently Reading
Poor Prognostic Factors Associated With Disease Progression in Patients With RA
August 18, 2018 – Alison Rodriguez
Opdivo Approved to Treat Metastatic SCLC
August 17, 2018 – Samantha DiGrande
Healthcare Costs Reduced When Osteoporosis Drugs Used Consistently, Study Says
August 17, 2018 – Allison Inserro
Vitamin D3 Status and MS Susceptibility is Genotype Dependent, Study Finds
August 17, 2018 – Alison Rodriguez
Experts Assess Link Between Misclassification of Obesity and Prevalence of Migraine
August 17, 2018 – Alison Rodriguez
What We're Reading: Free Medical School Tuition; NJ Reinsurance Program; Downplaying Addiction With Opioids
August 17, 2018 – AJMC Staff
AJMC® in the Press, August 17, 2018
August 17, 2018 – AJMC Staff
This Week in Managed Care: August 17, 2018
August 17, 2018
FDA Gives Teva Green Light for First Generic EpiPen
August 16, 2018 – Allison Inserro

What We're Reading: W.Va. Sues Drug Distributors for Fueling the Opioid Epidemic

AJMC Staff
What we're reading, December 28, 2016: a county in West Virginia is suing 3 national drug distributors for allegedly fueling the opioid epidemic; CDC awards new funding as another Zika case is reported in Texas; and first drug to treat spinal muscular atrophy approved.
A county in West Virginia, which has been hard hit by the opioid epidemic, is suing 3 of the nation’s largest prescription drug distributors. According to the Charleston Gazette-Mail, the lawsuit alleges that Cardinal Health, McKesson Corp, and AmerisourceBergen shipped an excessive number of opioids to the county and fueled the painkiller epidemic there. Meanwhile, Cardinal has settled with the state of New York over a similar case. The lawsuit claims the company failed to alert the Drug Enforcement Administration about suspiciously large orders of addictive painkillers in New York.  

With new cases of the Zika virus reported in Texas, the CDC is sending $184 million to states and territories to continue the fight against the virus. Florida, Hawaii, and Texas are the states that will receive the largest amounts, and Puerto Rico is receiving $5 million, reported The Washington Post. The new funding announcement comes on the heels of a sixth locally-borne case of Zika in Cameron County, Texas.

The first drug to treat spinal muscular atrophy was approved on Friday. Biogen’s drug will treat a disease that affects 1 in 10,000 live births and is the leading genetic cause of death among infants, according to Reuters. The drug is approved across the full range and severity of the disease and is projected to have annual sales reaching $2 billion. Clinical trials of nusinersen dramatically improved motor milestones and extended survival. 

Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!